Patent · US Active

Compounds

US11911372B2 · kind B2 · utility

0Cited by

9References

13Claims

0Family size

Assignee

CTXT PTY LTD · AU

Inventors

Paul Anthony Stupple · Melbourne, AU
Helen Rachel Lagiakos · Melbourne, AU
Richard Charles Foitzik · Elmore, AU
Michelle Ang Camerino · Melbourne, AU
George Nikolakopoulos · Melbourne, AU
Ylva Elisabet Bergman Bozikis · Melbourne, AU
Wilhelmus Johannes Antonius Kersten · Melbourne, AU
Scott Raymond Walker · Melbourne, AU
Jonathan Grant Hubert · Melbourne, AU

Key dates

Filing date	Jun 28, 2019
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Aug 11, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I), or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.